Meribank Biotech Co., Ltd (TPEX:4724)

Meribank Biotech Statistics

Total Valuation

TPEX:4724 has a market cap or net worth of TWD 1.35 billion. The enterprise value is 2.37 billion.

Market Cap	1.35B
Enterprise Value	2.37B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4724 has 87.98 million shares outstanding. The number of shares has increased by 31.49% in one year.

Current Share Class	87.98M
Shares Outstanding	87.98M
Shares Change (YoY)	+31.49%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	41.20%
Owned by Institutions (%)	n/a
Float	38.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.78
PB Ratio	1.12
P/TBV Ratio	3.85
P/FCF Ratio	38.35
P/OCF Ratio	24.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.00, with an EV/FCF ratio of 67.00.

EV / Earnings	-35.41
EV / Sales	4.86
EV / EBITDA	32.00
EV / EBIT	n/a
EV / FCF	67.00

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.94.

Current Ratio	1.58
Quick Ratio	1.37
Debt / Equity	0.94
Debt / EBITDA	13.52
Debt / FCF	32.18
Interest Coverage	-2.62

Financial Efficiency

Return on equity (ROE) is -7.43% and return on invested capital (ROIC) is -2.08%.

Return on Equity (ROE)	-7.43%
Return on Assets (ROA)	-1.65%
Return on Invested Capital (ROIC)	-2.08%
Return on Capital Employed (ROCE)	-2.05%
Revenue Per Employee	3.43M
Profits Per Employee	-470,704
Employee Count	142
Asset Turnover	0.24
Inventory Turnover	26.11

Taxes

Income Tax	-7.72M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.71% in the last 52 weeks. The beta is 0.62, so TPEX:4724's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-31.71%
50-Day Moving Average	16.14
200-Day Moving Average	17.10
Relative Strength Index (RSI)	40.92
Average Volume (20 Days)	85,481

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4724 had revenue of TWD 486.52 million and -66.84 million in losses. Loss per share was -0.76.

Revenue	486.52M
Gross Profit	228.50M
Operating Income	-53.36M
Pretax Income	-75.67M
Net Income	-66.84M
EBITDA	6.97M
EBIT	-53.36M
Loss Per Share	-0.76

Balance Sheet

The company has 136.20 million in cash and 1.14 billion in debt, with a net cash position of -1.00 billion or -11.37 per share.

Cash & Cash Equivalents	136.20M
Total Debt	1.14B
Net Cash	-1.00B
Net Cash Per Share	-11.37
Equity (Book Value)	1.21B
Book Value Per Share	13.63
Working Capital	130.47M

Cash Flow

In the last 12 months, operating cash flow was 56.25 million and capital expenditures -20.92 million, giving a free cash flow of 35.33 million.

Operating Cash Flow	56.25M
Capital Expenditures	-20.92M
Free Cash Flow	35.33M
FCF Per Share	0.40

Margins

Gross margin is 46.97%, with operating and profit margins of -10.97% and -13.74%.

Gross Margin	46.97%
Operating Margin	-10.97%
Pretax Margin	-15.55%
Profit Margin	-13.74%
EBITDA Margin	1.43%
EBIT Margin	-10.97%
FCF Margin	7.26%

Dividends & Yields

TPEX:4724 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.49%
Shareholder Yield	-31.49%
Earnings Yield	-4.93%
FCF Yield	2.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4724 has an Altman Z-Score of 0.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	4